Goldman Sachs
BIOA

Goldman Sachs’s BioAge Labs, Inc. Common Stock BIOA Stock Holding History

Goldman Sachs’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$102K Sell
24,792
-1,967
-7% -$8.12K ﹤0.01% 4874
2025
Q1 		$101K Sell
26,759
-169,208
-86% -$636K ﹤0.01% 4819
2024
Q4 		$1.13M Buy
195,967
+87,351
+80% +$506K ﹤0.01% 3844
2024
Q3 		$2.26M Buy
+108,616
New +$2.26M ﹤0.01% 3290